DRUCKEN

Ivan Đikić, MD, PhD

Professor of Biochemistry

Director of the Institute of Biochemistry II
Johann Wolfgang von Goethe University Frankfurt

Speaker of the CRC 1177 on Selective Autophagy

Research

The Dikic group is interested in deciphering the molecular mechanisms of cellular signaling pathways, which have a high relevance to human diseases such as cancer, neurodegenerative disorders and inflammation. Here, they focus on the two major cellular quality control pathways: the ubiquitin proteasome system and autophagy. Both pathways are involved in almost all cellular signaling processes and provide protection against rapid aging and various human diseases. Their research focus ranges from ubiquitin signaling networks, including the role of ubiquitination and phosphorylation as well as linear ubiquitin chains in immune response and pathogen defense, to the selectivity and specificity of autophagy, with an emphasis on selective autophagy receptors and adaptor proteins in different autophagy pathways as well as the relevance of selective autophagy for human diseases, such as neuropathies and ALS.

Research Group Dikic

Selected workshop-related publications

Selected Reviews

Mechanism and medical implications of mammalian autophagy.
Nature Reviews Molecular Cell Biology. 19 (6):349-364 doi: 10.1038/s41580-018-0003-4.
Dikic I, Elazar Z. (2018)

Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Trends in Molecular Medicine 22(9):769-783 doi: 10.1016/j.molmed.2016.07.005. 
Weishaupt JH, Hyman T, Dikic I. (2016)

Ubiquitination in disease pathogenesis and treatment.
Nature Medicine 20(11):1242-53 doi: 10.1038/nm.3739.
Popovic D, Vucic D, Dikic I. (2014)